Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis

Thromb Res. 1983 Jul 15;31(2):305-17. doi: 10.1016/0049-3848(83)90333-x.

Abstract

A familial abnormal antithrombin III (AT-III) is reported. The characteristic of the abnormality in this family is low heparin cofactor activity with normal progressive antithrombin activity and normal or rather increased level of AT-III antigen. The patient is a 23-year-old female who had suffered from recurrent thrombophlebitis involving her lower extremities. Her plasma AT-III antigen concentration was 54 mg/dl and progressive antithrombin and factor Xa inhibitory activities were of normal level. However, the heparin cofactor activity of her plasma was as low as 26% of normal control. On crossed immunoelectrophoresis (CIE) containing heparin in the first dimension agarose, patient's AT-III showed no increase in electrophoretic mobility compared to that in the absence of heparin, suggesting that the patient's AT-III has no affinity for heparin. From CIE pattern in the presence of heparin, the patient was found to be a homozygote, and parents and one of her younger sisters were heterozygotes. Thus, the mode of inheritance is proposed to be autosomal dominant.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antithrombin III / genetics*
  • Antithrombin III Deficiency
  • Blood Coagulation Tests
  • Female
  • Genes, Dominant
  • Genetic Variation*
  • Humans
  • Immunoelectrophoresis, Two-Dimensional
  • Pedigree
  • Recurrence
  • Thrombophlebitis / blood*

Substances

  • antithrombin III Toyama
  • Antithrombin III